Aip I features a compact peptide motif enriched with hydrophobic and polar residues that shape its conformational behavior. Researchers evaluate its folding dynamics to understand sequence-dependent interactions. Its structural profile supports modeling of receptor-binding determinants. Applications include structural biology, peptide engineering, and motif-function analysis.
CAT No: R2335
CAS No:200010-29-3
Synonyms/Alias:Autoinducing Peptide I;AIP I;200010-29-3;CHEMBL2337554;Autoinducing Peptide I trifluoroacetate salt;2-((3S,6S,9S,12S,15R)-15-(((2S,3R)-2-(((2S)-2-(((2S)-2-amino-3-(4-hydroxyphenyl)propanoyl)amino)-3-hydroxypropanoyl)amino)-3-hydroxybutanoyl)amino)-9-benzyl-6-((2S)-butan-2-yl)-3-(2-methylsulfanylethyl)-2,5,8,11,14-pentaoxo-1-thia-4,7,10,13-tetrazacyclohexadec-12-yl)acetic acid;2-[(3S,6S,9S,12S,15R)-15-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxybutanoyl]amino]-9-benzyl-6-[(2S)-butan-2-yl]-3-(2-methylsulfanylethyl)-2,5,8,11,14-pentaoxo-1-thia-4,7,10,13-tetrazacyclohexadec-12-yl]acetic acid;Staphylococcus aureus AIP-I;CHEBI:216866;HY-P4909;BDBM50526861;FA110179;CS-0674930;2-[(3S,6S,9S,12S,15R)-15-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxybutanoyl]amino]-9-benzyl-6-[(2S)-butan-2-yl]-3-(2-methylsulanylethyl)-2,5,8,11,14-pentaoxo-1-thia-4,7,10,13-tetrazacyclohexadec-12-yl]acetic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.